SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held biotech company advancing innovative cancer diagnostics, announced that Precision Pathology Services, a CAP/CLIA-certified ...
Sixty-three patients with advanced EGFR-mutant lung cancer at 7 Canadian centers, who were being screened for the ASTRIS trial (ClinicalTrials.gov identifier: NCT02474355), participated in this ...
Study finds MPS2 scores are highly reproducible across DRE and non-DRE urine samples alike. "This study reinforces the value of MPS2 as a non-invasive diagnostic tool that delivers consistent and ...
Next generation sequencing (NGS) has revolutionized molecular diagnostic testing. It is important to note that, as with many molecular diagnostic tests currently in clinical use, there are very few ...
As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their safety and efficacy. Method validation ensures the reliability of ...
Laboratory-based design verification testing (DVT) of combination products and medical devices must be performed to demonstrate that the device meets the performance requirements that were set in the ...
Design verification has been the biggest challenge for any IC design company for decades now. EDA tools and verification methods have evolved a lot over the last two decades, but along with that, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback